n(6)-carboxymethyllysine has been researched along with Focal Segmental Glomerulosclerosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, IY; Kwak, IS; Lee, DW; Lee, SB; Rhee, H; Seong, EY; Song, SH | 1 |
| Abe, M; Hisano, S; Horiuchi, S; Iwasaki, H; Nangaku, M; Sakata, N; Uesugi, N | 1 |
2 other study(ies) available for n(6)-carboxymethyllysine and Focal Segmental Glomerulosclerosis
| Article | Year |
|---|---|
An explorative analysis of secretory receptor for advanced glycation endproducts in primary focal segmental glomerulosclerosis.
Topics: Adolescent; Adult; Case-Control Studies; Female; Glomerulonephritis, IGA; Glomerulosclerosis, Focal Segmental; Humans; Lysine; Male; Middle Aged; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Regression Analysis; Young Adult | 2012 |
Possible mechanism for medial smooth muscle cell injury in diabetic nephropathy: glycoxidation-mediated local complement activation.
Topics: Acrolein; Adult; Aged; Aged, 80 and over; Arteriosclerosis; Complement Activation; Complement Membrane Attack Complex; Diabetic Nephropathies; Female; Glomerulosclerosis, Focal Segmental; Glycation End Products, Advanced; Humans; Hypertension; Kidney; Kidney Glomerulus; Lysine; Male; Middle Aged; Models, Biological; Nephrosclerosis; Oxidation-Reduction; Tunica Media | 2004 |